These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15641013)

  • 61. The parkin gene is not a major susceptibility locus for typical late-onset Parkinson's disease.
    Oliveri RL; Zappia M; Annesi G; Annesi F; Spadafora P; Pasqua AA; Tomaino C; Nicoletti G; Bosco D; Messina D; Logroscino G; Manobianca G; Epifanio A; Morgante L; Savettieri G; Quattrone A
    Neurol Sci; 2001 Feb; 22(1):73-4. PubMed ID: 11487208
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
    Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.
    Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG;
    Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism.
    Kuroda Y; Mitsui T; Akaike M; Azuma H; Matsumoto T
    J Neurol Neurosurg Psychiatry; 2001 Aug; 71(2):231-4. PubMed ID: 11459900
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Parkin analysis in early onset Parkinson's disease.
    Sironi F; Primignani P; Zini M; Tunesi S; Ruffmann C; Ricca S; Brambilla T; Antonini A; Tesei S; Canesi M; Zecchinelli A; Mariani C; Meucci N; Sacilotto G; Cilia R; Isaias IU; Garavaglia B; Ghezzi D; Travi M; Decarli A; Coviello DA; Pezzoli G; Goldwurm S
    Parkinsonism Relat Disord; 2008; 14(4):326-33. PubMed ID: 18519021
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.
    Chien HF; Rohé CF; Costa MD; Breedveld GJ; Oostra BA; Barbosa ER; Bonifati V
    Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel parkin mutations detected in patients with early-onset Parkinson's disease.
    Bertoli-Avella AM; Giroud-Benitez JL; Akyol A; Barbosa E; Schaap O; van der Linde HC; Martignoni E; Lopiano L; Lamberti P; Fincati E; Antonini A; Stocchi F; Montagna P; Squitieri F; Marini P; Abbruzzese G; Fabbrini G; Marconi R; Dalla Libera A; Trianni G; Guidi M; De Gaetano A; Boff Maegawa G; De Leo A; Gallai V; de Rosa G; Vanacore N; Meco G; van Duijn CM; Oostra BA; Heutink P; Bonifati V;
    Mov Disord; 2005 Apr; 20(4):424-431. PubMed ID: 15584030
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical and genetic analysis of juvenile parkinsonism in Russia].
    Zagorovskaia TB; Illarioshkin SN; Slominskiĭ PA; Ivanova-Smolenskaia IA; Markova ED; Limborskaia SA; Levin OS; Miloserdova OV; Proskokova TN; Bagyeva BKh; Brice A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):66-72. PubMed ID: 15554146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Parkin-proven disease: common founders but divergent phenotypes.
    Lincoln S; Wiley J; Lynch T; Langston JW; Chen R; Lang A; Rogaeva E; Sa DS; Munhoz RP; Harris J; Marder K; Klein C; Bisceglio G; Hussey J; West A; Hulihan M; Hardy J; Farrer M
    Neurology; 2003 May; 60(10):1605-10. PubMed ID: 12771249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.
    van de Warrenburg BP; Lammens M; Lücking CB; Denèfle P; Wesseling P; Booij J; Praamstra P; Quinn N; Brice A; Horstink MW
    Neurology; 2001 Feb; 56(4):555-7. PubMed ID: 11222808
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The clinical and genetic characteristics of autosomal recessive juvenile Parkinsonism in a Chinese family].
    Shen YW; Tang BS; Yan XX; Zhang YH; Guo JF; Jiang H
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):360-2. PubMed ID: 16009007
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
    Ferrara JM; Adam OR; Ondo WG
    Arch Neurol; 2010 Jan; 67(1):114-5. PubMed ID: 20065139
    [No Abstract]   [Full Text] [Related]  

  • 74. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
    Vidailhet M; Bonnet AM; Marconi R; Gouider-Khouja N; Agid Y
    Neurology; 1994 Sep; 44(9):1613-6. PubMed ID: 7936284
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Juvenile-onset parkinsonism with digenic parkin and PINK1 mutations treated with subthalamic nucleus stimulation at 45 years after disease onset.
    Nakahara K; Ueda M; Yamada K; Koide T; Yoshimochi G; Funayama M; Kim JH; Yamakawa S; Mori A; Misumi Y; Uyama E; Hattori N; Ando Y
    J Neurol Sci; 2014 Oct; 345(1-2):276-7. PubMed ID: 25106695
    [No Abstract]   [Full Text] [Related]  

  • 76. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
    Hedrich K; Marder K; Harris J; Kann M; Lynch T; Meija-Santana H; Pramstaller PP; Schwinger E; Bressman SB; Fahn S; Klein C
    Neurology; 2002 Apr; 58(8):1239-46. PubMed ID: 11971093
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    de Souza A; de Souza RJ
    Parkinsonism Relat Disord; 2017 Oct; 43():120-121. PubMed ID: 28729089
    [No Abstract]   [Full Text] [Related]  

  • 78. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
    Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
    Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
    Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
    Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Physiopathology of the dyskinesias induced by L-dopa].
    Grandas F; López-Ariztegui N
    Rev Neurol; 1997 Aug; 25 Suppl 2():S151-6. PubMed ID: 9280682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.